Elimination of infectious human immunodeficiency virus from human T-cell cultures by synergistic action of CD4-Pseudomonas exotoxin and reverse transcriptase inhibitors.
about
Pathogenesis of human immunodeficiency virus infectionPseudomonas exotoxin antisense RNA selectively kills hepatitis B virus infected cellsIn vitro inhibition of human immunodeficiency virus (HIV) type 1 replication by C2 symmetry-based HIV protease inhibitors as single agents or in combinationsAnti-human immunodeficiency virus type 1 activity of an anti-CD4 immunoconjugate containing pokeweed antiviral proteinSpecific killing of HIV-infected lymphocytes by a recombinant immunotoxin directed against the HIV-1 envelope glycoproteinImmunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirsAn immunotoxin targeting the gH glycoprotein of KSHV for selective killing of cells in the lytic phase of infectionAnti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID miceSpatial organization of Pseudomonas aeruginosa biofilms probed by combined matrix-assisted laser desorption ionization mass spectrometry and confocal Raman microscopy.Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition.Antiviral therapy for human immunodeficiency virus infectionsPotent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12.Strategies in the treatment of AIDS and related diseases: the lessons of cancer chemotherapy.Selective killing of Kaposi's sarcoma-associated herpesvirus lytically infected cells with a recombinant immunotoxin targeting the viral gpK8.1A envelope glycoprotein.Antiviral therapy: current concepts and practicesTargeted cytotoxic therapy: adapting a rapidly progressing anticancer paradigm for depletion of persistent HIV-infected cell reservoirs.Reconsidering targeted toxins to eliminate HIV infection: you gotta have HAARTImmunotoxins: the role of the toxin.Curing HIV: lessons from cancer therapyAnti-HIV double variable domain immunoglobulins binding both gp41 and gp120 for targeted delivery of immunoconjugates.Pseudomonas exotoxin and recombinant immunotoxins derived from it.Immune-based therapies for treatment of HIV infection.Increased affinity and stability of an anti-HIV-1 envelope immunotoxin by structure-based mutagenesis.
P2860
Q24634681-D8769F0B-C016-4B21-BB5D-592BF947F78CQ24648726-60A0E361-3A87-4850-91AB-6016B693C580Q28318476-8DBBB775-4C02-4529-A97D-DDF750D1CE08Q28378710-FD23E12D-D015-4C26-969D-F90916BA9C58Q30862548-866D0B23-617D-4D90-9ECC-B4F17C69C340Q33604776-06F13945-9811-441D-9631-E81FBD1EC74CQ35007502-06DDA55E-89BD-410F-86EA-442F82EF078FQ35171217-041F09F7-6C1E-4972-9235-D92E92F72477Q35177516-C3B2F255-4A30-4F95-AFBE-77507856AAF2Q35325810-F07FB66D-6524-4CBE-B5E7-8A967711527EQ35366050-0D06A24E-1729-41AC-AF1B-7EC6D73B9B7EQ35894716-196C436D-20A0-4162-89A8-DB0F679EC7DEQ35930774-23722876-43DD-4EA4-99C6-F16B4D838B5BQ35992503-D2056E3C-12F3-489B-A15F-7F7E0267EBEEQ36070394-EDEBC85D-683F-4082-850D-6C670B297938Q36073562-FF3178A7-A668-4D9C-B162-3077F87BB4E5Q36077381-0E407FFA-829D-4565-97A8-49225B266981Q37139525-9962A0DC-12A6-4BF4-9ED4-810F93523359Q38085989-087DCB7F-F3D4-41B7-9659-326EC78117DCQ39261383-6751F4BC-2994-42EE-AA33-AAA20606CBD2Q40841579-4F4EE5DF-530C-4728-ABB1-C25E612E9D9AQ40959127-8EC43C40-F9E5-4232-B90A-F1A217DB99C9Q44065007-B00107C4-5C5C-483F-BA74-AAC0BA52D7D1
P2860
Elimination of infectious human immunodeficiency virus from human T-cell cultures by synergistic action of CD4-Pseudomonas exotoxin and reverse transcriptase inhibitors.
description
1990 nî lūn-bûn
@nan
1990 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Elimination of infectious huma ...... erse transcriptase inhibitors.
@ast
Elimination of infectious huma ...... erse transcriptase inhibitors.
@en
type
label
Elimination of infectious huma ...... erse transcriptase inhibitors.
@ast
Elimination of infectious huma ...... erse transcriptase inhibitors.
@en
prefLabel
Elimination of infectious huma ...... erse transcriptase inhibitors.
@ast
Elimination of infectious huma ...... erse transcriptase inhibitors.
@en
P2093
P2860
P356
P1476
Elimination of infectious huma ...... verse transcriptase inhibitors
@en
P2093
D J FitzGerald
E A Berger
J N Weinstein
V K Chaudhary
P2860
P304
P356
10.1073/PNAS.87.22.8889
P407
P50
P577
1990-11-01T00:00:00Z